Park Ha Biological Technology is trading at $3.09 (+9.56%) in pre-market amid stronger biotechnology sentiment.
- The August 27 pre-market move follows a +8.88% gain to $2.82 on August 26, rebounding after the prior sessionβs decline.
- No fresh company-specific announcement dated August 26 or August 27 was identified; recent coverage points to XBI up 2.06%.
- Broader risk appetite is supportive, with Nasdaq futures up 0.84% and the Nasdaq Composite up 1.13%.